Supply, Implementation and Maintenance Tender - 147605015

Procurement Summary

Country: Netherlands

Summary: Supply, Implementation and Maintenance of a Validated Total Solution for Scid and Sma Screening for Multiple Laboratories

Deadline: 12 Oct 2026

Posting Date: 20 Aug 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 147605015

Document Ref. No.: 378a6503-7eca-4b12-a041-f692577d1cb2

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

CPV Classification

33696200 - Blood-testing reagents
38950000 - Polymerase Chain Reaction (PCR) equipment

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Supply, implementation and maintenance of a validated total solution for SCID and SMA screening for multiple laboratories Description: The neonatal heel prick screening (NHS) is a national screening program that is carried out at newborns in the first week after birth. In the Netherlands (European and Caribbean Netherlands), approximately 170, 000 newborns receive the heel prick every year. The heel prick screening is the longest-running national screening program in public health care. The analysis of the heel prick blood currently provides important information about twenty-seven rare, often hereditary, serious conditions. From 2026, the blood test will be carried out by three screening laboratories, including the screening laboratory of RIVMGZB acts as a reference laboratory. The screening laboratories are responsible for the analysis of the heel prick blood sample and timely reporting of the results. This will be used in all screening laboratories from January 2021 created a total solution for screening for SCID. From June 1, 2022, SMA has also been added to the program and the laboratories will screen with a multiplex Total Solution that can screen for both SCID and SMA. In addition, the possibility that in the coming years it will be decided that screening for X-linked agammaglobulinemia (XLA) should be performed. To ensure uniformity, RIVM has decided to keep the equipment (hardware), software, reagents and associated maintenance (preventive, corrective, adaptive), also called a Total Solution, and make it available to the screening laboratories. This Tender Procedure concerns an assignment for the delivery, implementation and maintenance of a validated Total Solution for the SCID and SMA screening for the screening laboratories. The purpose of this European tender is to conclude an Agreement with one Contractor, according to the principle of reagent rental, whereby the supplier remains the owner of the equipment. The The Contractor becomes fully responsible f...
Legal Framework: Procurement Act 2012 Command Type: Deliveries Procedure: Public Main assignment (CPV code): 33696200-7 Reagents for blood analysis Additional order(s) (CPV code): 38950000-9 Polymerase chain reaction (PCR) equipment Place of Performance NUTS code: Utrecht (NL350) Tenderned Reference Number: 607207 PB/S Number: 576741-2026

Documents

 Tender Notice